Inventera

BiotechnologySeries CSeoul, South Koreainventera.kr

Latest round

Series C

Last raised

Oct 2024

Total raised

$25M

Investors

11

About Inventera

Based in South Korea, Inventera Inc.Inventera Inc. was founded in 2018 and is headquartered in Seoul, South Korea. The company focuses on the creation and commercialization of its nanomedicine platform, Invinity™, designed for therapeutic advancements. The founder, Tae-hyun Shin, has a background in biotechnology and leads the company as CEO. Inventera has completed a total of 5 deals, with its most recent deal occurring on April 2, 2026.Inventera operates primarily through its innovative nanomedicine platform, Invinity™, which is designed for the development and commercialization of first-in-class therapeutics. This platform encompasses a range of applications, from diagnostic imaging agents to next-generation therapies, focusing on optimizing drug circulation time within the body to enhance efficacy. Invinity™ allows for targeted delivery of medications to specific tissues, improving therapeutic effects and reducing side effects.Inventera's revenue model is structured around partnerships and collaborations with pharmaceutical firms and healthcare institutions, focusing on the commercialization of its Invinity™ platform products. Business transactions typically occur through contractual agreements for the development and licensing of its technologies, facilitating integration into clients' offerings.Inventera plans to launch new products designed around its Invinity™ platform, with specific release dates to be determined as development progresses. The company is targeting expansion into additional markets in North America and Europe by 2027.18 million shares at KRW 16,600 each, within the expected price range.

Who invested in Inventera

11 investors across 4 rounds

See all investors in Inventera

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Oct 29, 2024

    Amount

    $13M

    Investors

    Locked

  2. Series B

    Sep 8, 2022

    Amount

    $7.4M

    Investors

    Locked

  3. Series A

    Aug 30, 2020

    Amount

    $4.2M

    Investors

    Locked

  4. Angel

    Nov 20, 2018

    Amount

    $0.1M

    Investors

    Locked

Questions about Inventera

Who invested in Inventera?

Inventera has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Inventera raised?

Inventera has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Inventera last raise money?

Inventera's most recent round on record is a Series C, in Oct 2024.

What does Inventera do?

Based in South Korea, Inventera Inc.

Where is Inventera headquartered?

Inventera is headquartered in Seoul, South Korea.

Which VCs invest in companies like Inventera?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Inventera's stage. Their profiles are linked below.

Raising like Inventera? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.